We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
301
Agenus
AGEN
$312M
$1.92M 0.05%
+64,370
New +$2.72M
FLYX icon
302
flyExclusive
FLYX
$63.7M
$1.92M 0.05%
+188,312
New +$1.9M
OCUL icon
303
Ocular Therapeutix
OCUL
$1.92B
$1.91M 0.05%
+363,286
New +$1.73M
IDYA icon
304
IDEAYA Biosciences
IDYA
$3.49B
$1.91M 0.05%
+138,949
New +$2.31M
MRSN
305
DELISTED
Mersana Therapeutics
MRSN
$1.9M 0.05%
+18,508
New +$2.6M
MRK icon
306
Merck
MRK
$317B
$1.9M 0.05%
+17,864
New +$1.93M
HIW icon
307
Highwoods Properties
HIW
$3.47B
$1.9M 0.05%
+81,952
New +$2.21M
ARYE
308
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$1.9M 0.04%
+185,349
New +$1.88M
SWKS icon
309
Skyworks Solutions
SWKS
$10.1B
$1.89M 0.04%
+16,006
New +$1.77M
IOVA icon
310
Iovance Biotherapeutics
IOVA
$2.77B
$1.88M 0.04%
+308,212
New +$2.13M
BCRX icon
311
BioCryst Pharmaceuticals
BCRX
$2.38B
$1.88M 0.04%
+225,764
New +$2.17M
NEWR
312
DELISTED
New Relic, Inc.
NEWR
$1.88M 0.04%
+25,000
New +$1.69M
LITT
313
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$1.87M 0.04%
+184,322
New +$1.86M
NFYS
314
DELISTED
Enphys Acquisition Corp.
NFYS
$1.86M 0.04%
+182,046
New +$1.84M
BKNG icon
315
Booking.com
BKNG
$156B
$1.86M 0.04%
+17,500
New +$1.7M
CNDA
316
DELISTED
Concord Acquisition Corp II
CNDA
$1.83M 0.04%
+180,304
New +$1.82M
GRTX
317
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.83M 0.04%
+713,531
New +$1.47M
SPT icon
318
Sprout Social
SPT
$492M
$1.83M 0.04%
+30,000
New +$1.84M
MU icon
319
Micron Technology
MU
$996B
$1.81M 0.04%
+30,000
New +$1.76M
ADT icon
320
ADT
ADT
$5.59B
$1.78M 0.04%
+246,182
New +$2.01M
SCYX icon
321
SCYNEXIS
SCYX
$51.6M
$1.76M 0.04%
+73,209
New +$973K
MRTX
322
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.76M 0.04%
+47,250
New +$2.13M
INCY icon
323
Incyte
INCY
$24B
$1.74M 0.04%
+24,100
New +$1.89M
IWM icon
324
PUT
iShares Russell 2000 ETF
IWM
$82.1B
$1.73M 0.04%
+2,230,000
New +$411M
VERA icon
325
Vera Therapeutics
VERA
$2.3B
$1.73M 0.04%
+223,468
New +$1.72M

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.